References
- Department-related parliamentary standing committee on health and family welfare. 59th report on the functioning of the Central Drugs Standard Control Organisation (CDSCO). 2012 May [cited 2019 Mar 28]. Available from: http://164.100.47.5/newcommittee/reports/EnglishCommittees/Committee%20on%20Health%20and%20Family%20Welfare/59.pdf
- Gautam CS, Saha L. Fixed dose drug combinations (FDCs): rational or irrational: a view point. Br J Clin Pharmacol. 2008;65:795–796.
- Pundlikrao IP. Fixed dose combination product: A review. Indian J Nov Drug Deliv. 2017;9:1–11.
- Kamath G Lessons we must learn from the fixed-dose combinations fiasco. 2018 [cited 2019 Mar 28]. Available from: https://www.moneycontrol.com/news/health-and-fitness/opinion-lessons-we-must-learn-from-the-fixed-dose-combinations-fiasco-2956901.html
- Harris G Medicines made in India set off safety worries. The New York Times. 2014 Feb 14 [cited 2019 Mar 30]. Available from: https://www.nytimes.com/2014/02/15/world/asia/medicines-made-in-india-set-off-safety-worries.html
- GVK biosciences: European medicines agency recommends suspending medicines over flawed studies. EMA/37763/2015. 2015 Jan 23 [cited 2019 Mar 30]. Available from: https://www.ema.europa.eu/en/documents/press-release/gvk-biosciences-european-medicines-agency-recommends-suspending-medicines-over-flawed-studies_en.pdf
- Ankush C, Virendra SL, Kiranshanker K, et al. A survey on doctor’s expectation from medical representative in Karnataka state. Int J Cur Res Rev. 2015;7:75–82.
- Manupriya. Unapproved combination pills crowding Indian pharmacies. Nat India. 2015. DOI: 10.1038/nindia.2015.78.
- What are FDC drugs and why has the govt decided to ban them? Business Today. 2018 [cited 2019 Apr 2]. Available from: https://www.businesstoday.in/sectors/pharma/what-are-fdc-drugs-and-why-has-the-govt-decided-to-ban-them/story/282350.html
- Sreedhar D, Janodia MD, Ligade VS, et al. Fixed dose combinations: rational or irrational? Curr Sci. 2008;95:581–583.
- Gupta YK, Ramachandran SS. Fixed dose drug combinations: issues and challenges in India. Indian J Pharmacol. 2016;48:347–349.
- Rayasam SP, Dudhgaonkar SS, Dakhale GN, et al. The irrational fixed dose combinations in the Indian drug market: an evaluation of prescribing pattern using WHO guidelines. Int J Basic Clin Pharmacol. 2013;2(4):452–457.
- Goswami N, Gandhi A, Patel P, et al. An evaluation of knowledge, attitude and practices about prescribing fixed dose combinations among resident doctors. Perspect Clin Res. 2013;4:130–135.
- Balat JD, Gandhi AM, Patel PP, et al. A study of use of ?xed dose combinations in Ahmedabad, India. Indian J Pharmacol. 2014;46:503–509.
- Sharma K, Sharma A, Singh V, et al. Irrational fixed dose combinations & need for intervention: understanding of dental clinicians and residents. J Clin Diagn Res. 2014;8:49–52.
- Ishrar SMG, Rathinavelu M, Reddy YP. Assessment of rational use of fixed dose combination in community pharmacies of resource limited settings of Andhra Pradesh. Int J Pharm Sci Res. 2016;7:2181–2186.
- Gangadhar M, Muthahanumaiah NK, Shivaraju PT. An evaluation of knowledge, attitude and practices about prescribing fixed dose combinations among postgraduates of a rural tertiary health care teaching hospital. Int J Basic Clin Pharmacol. 2016;5:2476–2480.
- Ahmed T, Khan TA, Chandel NB, et al. Rationality verses irrationality in fixed dose combinations: at a tertiary teaching hospital of rural Chhattisgarh, India. Int J Basic Clin Pharmacol. 2018;7:1114–1118.
- Belhekar MN, Bhave KA, Patel TC, et al. Evaluation of prescription pattern of fixed-dose combinations in a tertiary care hospital in India – A cross-sectional study. Natl J Physiol Pharm Pharmacol. 2019;9:1–6.
- McGettigan P, Roderick P, Mahajan R, et al. Use of fixed dose combination (FDC) drugs in India: central regulatory approval and sales of FDCs containing non-steroidal anti-inflammatory drugs (NSAIDs), metformin, or psychotropic drugs. PLoS Med. 2015;12:e1001826.
- Vendoti D Decoding the ban on irrational fixed-dose combination drugs in India. ORF occasional paper #177. 2018 Nov 29 [cited 2019 Apr 15]. Available from: https://www.orfonline.org/research/decoding-the-ban-on-irrational-fixed-dose-combination-drugs-in-india-45835/
- Roderick P, Mahajan R, McGettigan P, et al. India should introduce a new drugs act. Lancet. 2014;383:203–206.
- Bhaduri S, Kipgen T. ‘New drugs’ approvals in India: an institutional perspective. Sci Technol Soc. 2018;23:444–462.
- Fixed dose combinations approved by DCG (I) since 1961 till 22nd February 2019. 2019 Feb [cited 2019 Apr 15]. Available from: https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NDEwOQ==
- Revikumar KG, Veena R. Fixed dose combinations in indian medicine market – a SWOT analysis. MOJ Bioequiv Availab. 2017;4:276–280.
- Report of expert committee on evaluation of cases of fixed dose combinations (FDCs) considered as irrational and where showcause notices were issued to the applicants for submitting their replies. Central Drugs Standard Control Organisation, Directorate General of Health Services, Ministry of Health and Family Welfare, Govt. of India. 2016 Feb [cited 2019 Apr 15]. Available from: http://www.cdsco.nic.in/writereaddata/fdcreport10_2_2016.pdf
- National List of Essential Medicines (NLEM) 2015. CDSCO. 2015 [cited 2019 Apr 15]. Available from: http://cdsco.nic.in/WriteReadData/NLEM-2015/NLEM,%202015.pdf
- Singh GN To: all State/UT drug controllers. Subject: Approval of the safety and efficacy of Fixed Dose Combinations (FDCs) permitted for manufacture for sale in the country without due approval from the office of DCG (I)-regarding. F. No. 4-01/2013-DC (Misc13-PSC). 2013 Jul 5 [cited 2019 Apr 16]. Available from: http://www.cdsco.nic.in/writereaddata/Approval_of_the_safety_and%20efficacy_FDC.pdf
- Chaudhury RR Report of the Prof. Rajnit Roy Chaudhury expert committee to formulate policy and guidelines for approval of new drugs, clinical trials and banning of drugs. 2013 Jul 01 [cited 2019 Apr 16]. Available from: http://www.cdsco.nic.in/writereaddata/Report_of_Dr_Ranjit_Roy.pdf.
- Singh GN To: all State/UT drug controllers. Subject: Approval of the safety and efficacy of Fixed Dose Combinations (FDCs) permitted for manufacture for sale in the country without due approval from the office of DCG (I)-regarding. F. No. 4-01/2013-DC (Misc13-PSC). 2013 Jan 15 [cited 2019 Apr 16]. Available from: http://www.cdsco.nic.in/writereaddata/Approval_of_the_safety_and_efficacy_of_FDC.pdf
- Policy guidelines for approval of fixed dose combinations (FDCs) in India. CDSCO, Directorate General of Health Services, Ministry of Health & Family Welfare. 2013 June [cited 2019 Apr 16]. Available from: http://www.cdsco.nic.in/writereaddata/Report%20of%20Dr.C.K%20Kokate.pdf
- Minutes of the 79th meeting of Drugs Technical Advisory Board held on 16th May 2018 at DGHS, Nirman Bhawan, New Delhi. 2018 May [cited 2019 Apr 17]. Available from: http://www.cdsco.nic.in/writereaddata/Final%20Minutes%20for%2079th%20DTAB%20meeting%20held%20on%2016_05_2018(1).pdf
- Report of the DTAB subcommittee appointed on 19.02.2018 to examine matters related to 344 plus 5 FDCs in compliance with Hon. Supreme court order dated 15. 12.2017. 2018 Jul 19 [cited 2019 Apr 17]. Available from: https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/Committee/dtab_sub_report.pdf
- Reddy SE To: all State/UT drug controllers. prohibition of 328 fixed dose combinations by central government vide Gazette notification nos. S.O.4379 (E) to S.S.4706 (E) –regarding. F. No. 4-01/2013-DC (Misc13-PSC) Part II. 2018 Sept 14 [cited 2019 Apr 17]. Available from: http://cdsco.nic.in/writereaddata/banned%20FDC%20letter.pdf
- Complete list of 344 drugs banned by the ministry of health and family welfare. 2018 [cited 2019 Apr 17]. Available from: https://www.nhp.gov.in/Complete-list-of-344-drugs-banned-by-the-Ministry-of-Health-Family-welfare_pg